Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-18

Clinical Trial Update: Lapatinib in Combination With Vinorelbine [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated lapatinib in combination with vinorelbine for cancer; results from the completed trial were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lapatinib (Lapatinib)
  • Vinorelbine (Vinorelbine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-07-18